Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hisamitsu Pharmaceutical Inc

HPX
Current price
24.8 EUR 0 EUR (0.00%)
Last closed 3 991 JPY
ISIN JP3784600003
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Frankfurt Exchange
Capitalization 292 932 354 018 JPY
Yield for 12 month -23.18 %
1Y
3Y
5Y
10Y
15Y
HPX
21.11.2021 - 28.11.2021

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Address: Tashirodaikan-machi 408, Tosu, Japan, 841-0017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

619 113.53 JPY

P/E ratio

20.6611

Dividend Yield

2.15 %

Current Year

+141 705 999 951 JPY

Last Year

+128 330 000 049 JPY

Current Quarter

+35 809 999 937 JPY

Last Quarter

+38 878 999 930 JPY

Current Year

+78 970 999 964 JPY

Last Year

+72 700 000 017 JPY

Current Quarter

+20 805 000 043 JPY

Last Quarter

+20 371 000 035 JPY

Key Figures HPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 18 183 000 018 JPY
Operating Margin TTM 11.59 %
PE Ratio 20.6611
Return On Assets TTM 2.46 %
PEG Ratio
Return On Equity TTM 5.76 %
Wall Street Target Price 619 113.53 JPY
Revenue TTM 145 419 993 088 JPY
Book Value 3 607.41 JPY
Revenue Per Share TTM
Dividend Share 85 JPY
Quarterly Revenue Growth YOY 11.6 %
Dividend Yield 2.15 %
Gross Profit TTM 70 067 000 000 JPY
Earnings per share 193.31 JPY
Diluted Eps TTM 193.31 JPY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 22.6 %
Profit Margin 10.11 %

Dividend Analytics HPX

Dividend growth over 5 years

-48 %

Continuous growth

2 years

Payout Ratio 5 years average

45 %

Dividend History HPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 86
Ex Dividend Date 27.02.2025
Forward Annual Dividend Yield 2.15 %
Last Split Factor 2:1
Payout Ratio 23.07 %
Last Split Date 27.06.2000
Dividend Date

Stock Valuation HPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 20.6611
Forward PE
Enterprise Value Revenue 1.1785
Price Sales TTM 2.0144
Enterprise Value EBITDA 8.3965
Price Book MRQ 1.1072

Financials HPX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HPX

For 52 weeks

3 598.25 JPY 5 435.91 JPY
50 Day MA 3 973.18 JPY
Shares Short Prior Month
200 Day MA 4 022.94 JPY
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

M

MBC

15.81 USD MasterBrand Inc. -0.22 (-1.37%)
Detailed analytics
R

RNW

5.89 USD Renew Energy Global PLC 0 (0%)
Detailed analytics
I

I3H

2 160.00 EUR Interroll Holding AG 0 (0%)
Detailed analytics
D

DMP

32.45 EUR Dermapharm Holding SE +0.06 (+0.15%)
Detailed analytics
7

7JU

5.02 EUR RENEW ENG.GLB.A DL-0001 -0.01 (-0.1%)
Detailed analytics